Suzanna Noy

Suzanna Noy

Auto-generated profile, based on publicly available information

Suzanna Noy

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2017 in Brain
Verified
Journal Article
Open access
PDF file
DADevoy Anny
Devoy Anny
BKBernadett Kalmar
Bernadett Kalmar
MSMichelle Stewart
Michelle Stewart
HPHeesoon Park
Heesoon Park
BBBeverley Burke
Beverley Burke
EFElizabeth M C Fisher
Elizabeth M C Fisher
Mutations in FUS are causative for amyotrophic lateral sclerosis with a dominant mode of inheritance. In trying to model FUS-amyotrophic lateral sclerosis (ALS) in mouse it is clear that FUS is dosage-sensitive and effects arise from overexpression per se in transgenic strains. Novel models are required that maintain physiological levels of FUS expression and that recapitulate the human disease—with progressive loss of motor neurons in heterozygous animals. Here, we describe a new humanized FUS-ALS mouse with a frameshift mutation, which fulfils both criteria: the FUS Delta14 mouse. Heterozygous animals express mutant humanized FUS protein at physiological levels and have adult onset progressive motor neuron loss and denervation of neuromuscular junctions. Additionally, we generated a novel antibody to the unique human frameshift peptide epitope, allowing specific identification of mutant FUS only. Using our new FUSDelta14 ALS mouse-antibody system we show that neurodegeneration occurs in the absence of FUS protein aggregation. FUS mislocalization increases as disease progresses, and mutant FUS accumulates at the rough endoplasmic reticulum. Further, transcriptomic analyses show progressive changes in ribosomal protein levels and mitochondrial function as early disease stages are initiated. Thus, our new physiological mouse model has provided novel insight into the early pathogenesis of FUS-ALS.

1 January 2020 in Cell Reports
Verified
Journal Article
Open access
PCPishan Chang
Pishan Chang
DBDaniel Bush
Daniel Bush
SSStephanie Schorge
Stephanie Schorge
MGMark Good
Mark Good
TCTara Canonica
Tara Canonica
EFElizabeth M.C. Fisher
Elizabeth M.C. Fisher
Altered neural dynamics in the medial prefrontal cortex (mPFC) and hippocampus may contribute to cognitive impairments in the complex chromosomal disorder Down syndrome (DS). Here, we demonstrate non-overlapping behavioral differences associated with distinct abnormalities in hippocampal and mPFC electrophysiology during a canonical spatial working memory task in three partially trisomic mouse models of DS (Dp1Tyb, Dp10Yey, and Dp17Yey) that together cover all regions of homology with human chromosome 21 (Hsa21). Dp1Tyb mice show slower decision-making (unrelated to the gene dose of DYRK1A, which has been implicated in DS cognitive dysfunction) and altered theta dynamics (reduced frequency, increased hippocampal-mPFC coherence, and increased modulation of hippocampal high gamma); Dp10Yey mice show impaired alternation performance and reduced theta modulation of hippocampal low gamma; and Dp17Yey mice are not significantly different from the wild type. These results link specific hippocampal and mPFC circuit dysfunctions to cognitive deficits in DS models and, importantly, map them to discrete regions of Hsa21.

1 February 2010 in The American Journal of Pathology
Verified
Journal Article
Closed access
Rachel AllavenaRachel Allavena
Rachel Allavena
SNSuzanna Noy
Suzanna Noy
MAMarcus Andrews
Marcus Andrews
NPNick Pullen
Nick Pullen

1 July 2018 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
HWHeather T. Whittaker
Heather T. Whittaker
SZShenghua Zhu
Shenghua Zhu
DCDomenico L. Di Curzio
Domenico L. Di Curzio
RBRichard Buist
Richard Buist
XLXin-Min Li
Xin-Min Li
MMMelanie Martin
Melanie Martin